{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:07:59Z","timestamp":1761674879676},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1006\/cyto.2002.1956","type":"journal-article","created":{"date-parts":[[2002,8,28]],"date-time":"2002-08-28T16:33:28Z","timestamp":1030552408000},"page":"85-93","source":"Crossref","is-referenced-by-count":17,"title":["CYTOKINE PRODUCTION IN LINOMIDE-TREATED NOD MICE AND THE POTENTIAL ROLE OF A Th1\/Th2 SHIFT ON AUTOIMMUNE AND ANTI-INFLAMMATORY PROCESSES"],"prefix":"10.1006","volume":"19","author":[{"given":"Lola","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Barak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Zeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Abdul-Hai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Raibstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoshana","family":"Reich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Hirschfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/cyto.2002.1956_RF1","first-page":"622","article-title":"Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study","volume":"60","author":"Miyazaki","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1006\/cyto.2002.1956_RF2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0029-1210647","article-title":"Immune disturbance and pathogenesis of non-obese diabetes-prone (NOD) mice","volume":"89","author":"Harada","year":"1987","journal-title":"Exp Clin Endocrinol"},{"key":"10.1006\/cyto.2002.1956_RF3","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/BF00399792","article-title":"Prevention of diabetes in non-obese diabetic mice by Linomide, a novel immunomodulating drug","volume":"37","author":"Gross","year":"1994","journal-title":"Diabetologial"},{"key":"10.1006\/cyto.2002.1956_RF4","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1073\/pnas.90.14.6400","article-title":"Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator Linomide (quinoline-3\u2013carboxamide)","volume":"90","author":"Karussis","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1006\/cyto.2002.1956_RF5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.1780291115","article-title":"Successful treatment of autoimmunity in MRL\/1 mice with LS-2616, a new immunomodulator","volume":"29","author":"Tarkowski","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1006\/cyto.2002.1956_RF6","first-page":"580","article-title":"Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice","volume":"59","author":"Tarkowski","year":"1986","journal-title":"Immunol"},{"key":"10.1006\/cyto.2002.1956_RF7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/clin.1994.1027","article-title":"Lymphokines in autoimmunity\u2014a critical review","volume":"70","author":"Schattner","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1006\/cyto.2002.1956_RF8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0952-7915(92)90082-P","article-title":"Interleukin-10","volume":"4","author":"De Waal","year":"1992","journal-title":"Curr Opin Immunol"},{"key":"10.1006\/cyto.2002.1956_RF9","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.4049\/jimmunol.149.7.2378","article-title":"IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells","volume":"149","author":"Yssel","year":"1992","journal-title":"J Immunol"},{"key":"10.1006\/cyto.2002.1956_RF10","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells","volume":"146","author":"Fiorentino","year":"1991","journal-title":"J of Immunol"},{"key":"10.1006\/cyto.2002.1956_RF11","unstructured":"The TNF family, Cytokine Reference, Oppenheim, JJFeldmann, M, 375, 513"},{"key":"10.1006\/cyto.2002.1956_RF12","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1073\/pnas.87.6.2239","article-title":"Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes","volume":"87","author":"Held","year":"1990","journal-title":"Proc Natl Acad Sci"},{"key":"10.1006\/cyto.2002.1956_RF13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.180.3.995","article-title":"Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice","volume":"180","author":"Yang","year":"1994","journal-title":"J Exp Med"},{"key":"10.1006\/cyto.2002.1956_RF14","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.4049\/jimmunol.160.7.3585","article-title":"Dendritic cells and macrophages are the first and major producers of TNF\u03b1 in pancreatic islets in the non-obese diabetic mouse","volume":"160","author":"Dahl\u00e9n","year":"1998","journal-title":"J Immunol"},{"key":"10.1006\/cyto.2002.1956_RF15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0167-5699(96)30011-X","article-title":"IL-12: a key cytokine in immune regulation","volume":"17","author":"Lamont","year":"1996","journal-title":"Immunol Today"},{"key":"10.1006\/cyto.2002.1956_RF16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0145-2126(95)00110-7","article-title":"The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors","volume":"20","author":"Condiotti","year":"1996","journal-title":"Leuk Res"},{"key":"10.1006\/cyto.2002.1956_RF17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/08916930008994093","article-title":"Inhibition of autimmune disease by the immunomodulator linomide correlates with the ability to activate macrophages","volume":"32","author":"Dahl\u00e9n","year":"2000","journal-title":"Autoimmunity"},{"key":"10.1006\/cyto.2002.1956_RF18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1359-6101(98)00009-4","article-title":"The role of helper T cell subsets in autoimmune diseases","volume":"9","author":"Lafaille","year":"1998","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1006\/cyto.2002.1956_RF19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.7618088","article-title":"Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in Th1 cells","volume":"269","author":"Pernis","year":"1995","journal-title":"Science"},{"key":"10.1006\/cyto.2002.1956_RF20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1126\/science.7761837","article-title":"T helper cell subsets in insulin-dependent diabetes","volume":"268","author":"Katz","year":"1995","journal-title":"Science"},{"key":"10.1006\/cyto.2002.1956_RF21","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI118006","article-title":"In vivo activity and in vitro specificity of CD4\u2192Th1 and Th2 cells derived from the spleens of diabetic NOD mice","volume":"95","author":"Healey","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1006\/cyto.2002.1956_RF22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.186.2.299","article-title":"T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised non-obese diabetic (NOD) mice","volume":"186","author":"Pakala","year":"1997","journal-title":"J Exp Med"},{"key":"10.1006\/cyto.2002.1956_RF23","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1084\/jem.179.4.1379","article-title":"Production of interleukin 10 by islet cells accelerates immune mediated destruction of beta cells in non-obese diabetic mice","volume":"179","author":"Wogensen","year":"1994","journal-title":"J Exp Med"},{"key":"10.1006\/cyto.2002.1956_RF24","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4049\/jimmunol.166.2.1352","article-title":"Th1 to Th2 cytokine shifts in non-obese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation","volume":"166","author":"Serreze","year":"2001","journal-title":"J Immunol"},{"key":"10.1006\/cyto.2002.1956_RF25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/jaut.2001.0507","article-title":"An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice","volume":"16","author":"Suarez-Pinzon","year":"2001","journal-title":"J Autoimmun"},{"key":"10.1006\/cyto.2002.1956_RF26","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4049\/jimmunol.158.3.1402","article-title":"Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL\/Mp-1pr\/lpr mice","volume":"158","author":"Hortelano","year":"1997","journal-title":"J Immunol"},{"key":"10.1006\/cyto.2002.1956_RF27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.180.3.995","article-title":"Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process","volume":"180","author":"Yang","year":"1994","journal-title":"J Exp Med"},{"key":"10.1006\/cyto.2002.1956_RF28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1097-0045(199609)29:3<183::AID-PROS4>3.0.CO;2-F","article-title":"The antiangiogenic agent Linomide inhibits tumor necrosis factor \u2013 alpha secretion via inhibition of its synthesis","volume":"29","author":"Joseph","year":"1996","journal-title":"Prostate"},{"key":"10.1006\/cyto.2002.1956_RF29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0165-5728(96)00197-X","article-title":"Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myathemia gravis","volume":"73","author":"Zhang","year":"1997","journal-title":"Neuroimmunol"},{"key":"10.1006\/cyto.2002.1956_RF30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/clin.1994.1068","article-title":"Recombinant human IL-10 prevents the onset of diabetes in the non-obese diabetic mouse","volume":"71","author":"Pennline","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1006\/cyto.2002.1956_RF31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","article-title":"Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression","volume":"174","author":"De Waal Malefyt R","year":"1991","journal-title":"J Exp Med"},{"key":"10.1006\/cyto.2002.1956_RF32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-2249.1996.d01-751.x","article-title":"Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524\u2013543 reduces cyclophosphamide-accelerated diabetes","volume":"105","author":"Sai","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1006\/cyto.2002.1956_RF33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.iy.11.040193.001121","article-title":"Interleukin-10","volume":"11","author":"Moore","year":"1993","journal-title":"Ann Rev Immunol"},{"key":"10.1006\/cyto.2002.1956_RF34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0404.1998.tb01726.x","article-title":"Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis","volume":"98","author":"Tian","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"10.1006\/cyto.2002.1956_RF35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.181.2.817","article-title":"Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice","volume":"181","author":"Trembleau","year":"1995","journal-title":"J Exp Med"},{"key":"10.1006\/cyto.2002.1956_RF36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1749-6632.1996.tb52673.x","article-title":"Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice","volume":"795","author":"O'Hara","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"10.1006\/cyto.2002.1956_RF37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0168-8227(98)00130-2","article-title":"Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients","volume":"43","author":"Ng","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1006\/cyto.2002.1956_RF38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2567.1999.00836.x","article-title":"Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease","volume":"97","author":"Nicoletti","year":"1999","journal-title":"Immunology"},{"key":"10.1006\/cyto.2002.1956_RF39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.189.2.347","article-title":"The role of macrophages in T cell-mediated autoimmune diabetes in non-obese diabetic mice","volume":"189","author":"Jun","year":"1999","journal-title":"J Exp Med"},{"key":"10.1006\/cyto.2002.1956_RF40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08916930108995992","article-title":"Linomide does not prevent spontaneous autoimmune thyroiditis in NOD mice","volume":"33","author":"Hartoft-Nielsen","year":"2001","journal-title":"Autoimmunity"},{"key":"10.1006\/cyto.2002.1956_RF41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.97.1.285","article-title":"Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody","volume":"4;97","author":"Weiss","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/cyto.2002.1956_RF42","first-page":"1121","article-title":"Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture","volume":"143","author":"Wollenberg","year":"1993","journal-title":"Am J Pathol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466602919563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466602919563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:42:15Z","timestamp":1682325735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466602919563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S1043466602919563"],"URL":"https:\/\/doi.org\/10.1006\/cyto.2002.1956","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}